1) Hemorrhagic transformation
出血性转化
1.
The Brain Injury of Hemorrhagic Transformation after Cerebral Infarction in Rats and Effects of K_(ATP) Channels;
大鼠脑梗死后出血性转化脑损伤机制的研究及K_（ATP）通道的作用
2.
Explore of influence factors on the prognosis of patients with hemorrhagic transformation after cerebral infarction
影响脑梗死后出血性转化患者预后因素的探讨
3.
Hemorrhagic transformation after non-embolic cerebral infarction(with Clinical Analysis of 19 Cases)
非栓塞性脑梗死的出血性转化(附19例分析)
2) Hemorrhagic transformation
出血转化
1.
Objective To investigate the effects of recombinant tissue-type plasminogen activator (rt-PA) combined with mild hypothermia on the hemorrhagic transformation after cerebral ischemia-reperfusion within or out of the therapeutic time window in rats.
目的观察缺血3h时间窗内和超过时间窗采用重组组织型纤溶酶原激活剂(rt-PA)和rt-PA联合亚低温对脑缺血再灌注后出血转化干预的效果。
2.
Part ⅠStudy on Impact Factors for SpontaneousHemorrhagic Transformation in Ischemic StrokeBackground: Identifying significant predictors of hemorrhagic transformation (HT) would be helpful not only in improvement of diagnosis 、 treatment and prognosis of patients with HT, but also in guiding selection of candidates for thrombolysis.
第一部分 缺血性卒中自发性出血转化影响因素的研究 背景:确定缺血性卒中出血转化(Hemorrhagic Transformation,HT)的影响因素,不仅有助于改善出血转化的诊断、治疗和预后,更重要的是有助于更好地选择溶栓治疗的适应者。
3.
Objective: To investigate the effect of hyperglycaemia on the prognosis of acute cerebral infarction with treated with recombinant human tissue -type plasminogen activator,rt-PA, and the correlation between hypergly- caemia and hemorrhagic transformation.
目的:探讨入院高血糖对应用重组人组织纤溶酶原激活剂(recombinant human tissue-type plasminogen activator,rt-PA)溶栓治疗急性脑梗死患者预后的影响,以及是否与溶栓治疗后的出血转化相关。
3) symptomatic hemorrhagic transformation
症状性出血性转化
4) Hemorrhagic transformation
出血性转换
1.
Objective To examine the characteristics and the natural frequency of hemorrhagic transformation (HT) in a rat embolic stroke model and the effect of thrombolysis therapy.
目的 研究大鼠血栓栓塞性脑梗死后并发出血性转换(hemorrhagic transformation,HT)的自然发生率、特点及溶栓治疗对其影响,探讨HT的可能机制。
5) peptic ulcer bleeding
消化性溃疡出血
1.
Clinical characteristics of nonsteroidal anti-inflammatory drugs induced peptic ulcer bleeding;
非甾体抗炎药物致消化性溃疡出血的临床特征
2.
METHODS:Using pharmacoeconomical cost-effectiveness analysis,four therapeutic schemes for treating peptic ulcer bleeding,schemes A,B,C and D,were compared.
方法 :运用药物经济学成本 -效果分析法对4种消化性溃疡出血用药方案 ,即对A、B、C、D方案进行回顾性分析、评价。
6) Peptic ulcer hemorrhage
消化性溃疡出血
1.
Intravenous pantoprazole for the management of peptic ulcer hemorrhage:A clinical analyse of 35 cases;
潘托拉唑治疗消化性溃疡出血35例疗效观察
2.
Treatment observation of pantoprazole effect on peptic ulcer hemorrhage
泮托拉唑粉针治疗消化性溃疡出血的疗效观察
补充资料：出血性肠炎
出血性肠炎
hemorrhagic enteritis
为小肠的急性炎症，因有广泛性肠组织出血而名。绝大多数为4～10岁儿童，春夏季多发，病因不明，可能与肠道非特异性感染及机体过敏反应等有关。典型病理为坏死性炎性病变。起病急骤，主要表现为腹痛、呕吐、腹泻、血便及发热，不少患儿于1～2日内出现严重
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条